The history of Sildenafil presents a challenging picture for investors. While the initial release generated substantial profits, the end of its patent opened the avenue to off-brand versions, dramatically diminishing https://bookmarkbooth.com/story21664283/the-copyright-and-the-pharmaceutical-industry-a-risky-opportunity